Hyperfine (HYPR) versus Its Competitors Head-To-Head Review

Hyperfine (NASDAQ:HYPRGet Rating) is one of 69 public companies in the “Electromedical equipment” industry, but how does it weigh in compared to its competitors? We will compare Hyperfine to similar businesses based on the strength of its dividends, profitability, analyst recommendations, earnings, institutional ownership, valuation and risk.

Profitability

This table compares Hyperfine and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Hyperfine -1,479.40% -54.01% -49.87%
Hyperfine Competitors -694.79% -44.32% -25.31%

Valuation and Earnings

This table compares Hyperfine and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Hyperfine $1.50 million -$64.85 million -0.22
Hyperfine Competitors $1.03 billion $130.62 million 0.72

Hyperfine’s competitors have higher revenue and earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Insider & Institutional Ownership

23.9% of Hyperfine shares are held by institutional investors. Comparatively, 44.7% of shares of all “Electromedical equipment” companies are held by institutional investors. 26.1% of Hyperfine shares are held by insiders. Comparatively, 11.3% of shares of all “Electromedical equipment” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent recommendations for Hyperfine and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hyperfine 0 1 2 0 2.67
Hyperfine Competitors 89 601 1659 78 2.71

Hyperfine presently has a consensus price target of $4.30, suggesting a potential upside of 438.31%. As a group, “Electromedical equipment” companies have a potential upside of 83.41%. Given Hyperfine’s higher possible upside, equities analysts plainly believe Hyperfine is more favorable than its competitors.

Volatility & Risk

Hyperfine has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500. Comparatively, Hyperfine’s competitors have a beta of 13.35, indicating that their average stock price is 1,235% more volatile than the S&P 500.

Summary

Hyperfine competitors beat Hyperfine on 11 of the 13 factors compared.

Hyperfine Company Profile

(Get Rating)

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.